Axsome Therapeutics, Inc (AXSM) — Analysis Summary

Axsome Therapeutics, Inc (AXSM) has a market cap of $10.62B with year-over-year revenue growth of +42.5%. Net margin stands at -74.5%. The stock trades at a P/E ratio of -37.0.

Key Takeaways

• Revenue changed +42.5% year-over-year
• Net margin of -74.5%
• P/E ratio of -37.0

Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, AXSM posted revenue growth of +42.5% and trades at a P/E of -37.0.